Related Experiment Videos
Cost of informal care for diabetic patients in Thailand
Susmita Chatterjee1, Arthorn Riewpaiboon, Piyanuch Piyauthakit
1Division of Social and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447, Sri Ayutthaya Road, Bangkok 10400, Thailand. s_chatterjee_123@yahoo.com
Aims:
The study estimated the cost of informal care for 475 randomly selected diabetic patients as identified by International Classification of Diseases, tenth revision (ICD-10 codes=E10-E14) and who received treatment at Waritchaphum hospital in Sakhon Nakhon province of Thailand during the financial year 2008.
Methods:
Informal care was valued by using revealed preference method. Information of informal caregiving was collected through direct personal interview method either from the patients or from the caregivers. The data on time spent for informal care were collected by using recall method.
Results:
The study covered a total of 190 informal caregivers. Average time spent on informal care was 112.38h per month. The estimated cost of informal care was USD 110,713.08 using opportunity cost approach and USD 93,896.52 using proxy good method in 2008 (1 USD=32 Thai Baht).
Conclusions:
The study concluded that the hidden cost associated with informal caregiving is a burden for the Thai society. Hence, the economic cost associated with informal caregiving should be considered for future analyses of both the public health consequences of diabetes and interventions aimed at decreasing diabetic complications.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia
Traditional Level Of Health Care System
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
Diabetic Retinopathy
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes III: Clinical Manifestations